
Overview
Fresenius Nephrocare Polska is involved in providing chronic and acute kidney dialysis services and therapeutic apheresis. The company offers products and therapies specifically designed for healthcare professionals and patients dealing with chronic kidney disease. Additionally, they engage in research related to hemodiafiltration and its impact on hospitalization for end-stage kidney disease (ESKD).
Financials
Revenue history (in m)
From the notes
| Current income tax (CIT due) | $3,549,368 |
Filing timeliness
3 of 6 financial statements were filed late (the longest delay 87 days for 2021). All were audited by a statutory auditor.
- 202506/07/2026
- 202408/07/2025
- 202310/09/2024
- 202222/09/2023
- 202110/10/2022
- 202014/10/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
- Hospital activities (86.10.Z) Primary
Offer
- Kidney dialysis
- Acute dialysis
- Therapeutic apheresis
Websites
The sites are available in: Polish, English, German, Spanish, Czech and 7 more. The sites target these markets: United Kingdom, United States, Spain, Czechia, Sweden and 7 more.
- freseniusmedicalcare.comHome | Fresenius Medical CareApache
- dializygoscinne.plDializy gościnneWordPress 7.1Google Tag ManagerLLiteSpeed
Public procurement
No recorded participation in tenders.
The company is the contractor in 3 public sector contracts, worth USD 60.65k in total. They were signed with 3 public buyers.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Oct 19, 2026 | Repair | $734.05 | Szpital Bielański Im.Ks. Jerzego Popiełuszki Samodzielny Publiczny Zakład Opieki Zdrowotnej | |
| Jul 16, 2026 | Provision of medical services to ensure the provision of haemodialysis to the contracting party. | $24,797 | Samodzielny Publiczny Zakład Opieki Zdrowotnej w Kraśniku | |
| Jul 1, 2026 | Acute haemodialysis | $35,116 | Szpital Uniwersytecki Nr 2 Im. Dr Jana Biziela w Bydgoszczy |
National Health Fund (NFZ) contracts
The company has been an NFZ healthcare provider since 2008. In 2026 it is performing 63 contracts with a total value of USD 166.69m. All its contracts were worth USD 2.09bn in total.
NFZ contract value by year (in m USD)
| Type of care | NFZ branch | Contracts | Value in 2026 |
|---|---|---|---|
| Separately contracted healthcare services | małopolskie | 1 | USD 25.50m |
| Separately contracted healthcare services | wielkopolskie | 1 | USD 23.95m |
| Separately contracted healthcare services | mazowieckie | 1 | USD 18.95m |
| Separately contracted healthcare services | śląskie | 1 | USD 15.44m |
| Separately contracted healthcare services | dolnośląskie | 1 | USD 15.08m |
NFZ waiting lists
This company's facilities run 263 NFZ waiting lists. Waiting time forecast by NFZ, as of 16.11.2026.
| Service | Facility | Waiting time | Urgent | Waiting | |
|---|---|---|---|---|---|
| Outpatient dialysis unit | Bielsko-Biała | no wait | no wait | 0 | |
| Outpatient dialysis unit | Bydgoszcz | no wait | no wait | 0 | |
| Outpatient dialysis unit | Chełm | no wait | no wait | 0 | |
| Outpatient dialysis unit | Częstochowa | no wait | no wait | 0 | |
| Outpatient dialysis unit | Drawsko Pomorskie | no wait | no wait | 0 |
Job offers
The company has its own careers page: jobs.freseniusmedicalcare.com.
Authorized Representatives
Manner of representation
If the management board is a one-person management board, the sole member of the management board represents the company independently. If the management board is a multi-member management board, the company may be represented by two members of the management board jointly, or by one member of the management board jointly with one commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 271,704 | $36,696,920.58 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Capital group
The company belongs to the Fresenius Medical Care AG (Germany) group, which is its direct owner. The group has 70 companies, 66 of them abroad.
| Name | Country |
|---|---|
| Fresenius Medical Care Polska | |
| Fresenius Medical Care Ssc | |
| Biocare Technology Company Limited | |
| FMC Finance II S.A R.L. | |
| Fresenius Management Services, Inc. |
Bank accounts
Registered as a VAT taxpayer on 2002-01-01.
42 1880 0009 0000 0011 0155 9000
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $2.2M$2,183,610 |
Buildings and premises | $9.8M$9,758,468 |
MSiG notices
| Publication date | Event | |
|---|---|---|
| Aug 9, 2013 | Commercial Companies Code notice | |
| Jul 11, 2013 | Commercial Companies Code notice | |
| Sep 14, 2010 | Commercial Companies Code notice | |
| Sep 14, 2010 | Commercial Companies Code notice | |
| Jun 10, 2010 | Merger plan |
Public aid
No public aid cases recorded in the last 10 years.
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2018-04-02 | Disease won't wait, so don't you wait either – developing cancer prevention focused on detecting colorectal cancer in Powiat Łobeski by NZOZ INTERMED Sp. z o.o. | $482.9K$482,943 | Regional Operational Programme of the Zachodniopomorskie Voivodeship 2014-2020 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Change history
| Date | Event | |
|---|---|---|
| 2013-07-01 | Share capital increase (99,071,500.00 PLN → 135,852,000.00 PLN) | |
| 2012-04-27 | Share capital reduction (102,124,000.00 PLN → 99,071,500.00 PLN) | |
| 2010-02-18 | Share capital increase (98,548,000.00 PLN → 102,124,000.00 PLN) | |
| 2008-10-30 | Share capital increase (89,698,000.00 PLN → 98,548,000.00 PLN) | |
| 2008-04-28 | Share capital increase (84,211,000.00 PLN → 89,698,000.00 PLN) |
FAQ
Last updated: 2026-10-07